Digital Health Global

APRIL 25, 2024

The study, led by principal investigator Nitin Ohri, M.D., This pilot study represents a critical step in leveraging digital health technology to enhance cancer treatment outcomes,” said John Wagner, M.D., Chief Medical Officer, Koneksa. Chief Medical Officer, Koneksa. “By

Health Data 88

Health Data BioTech Drug Development healthcare technology 88

Digital Health Global

JUNE 13, 2023

The LEARNS study will investigate the Koneksa neuroscience solution, as well as the Beacon Biosignals platform, applied to at-home EEG, compared with in-clinic polysomnography, in neurological and sleep disorders. Beacon’s mobile EEG will join more than a dozen digital health technologies that are already integrated into the Koneksa solution.

Drug Development 88

Drug Development eMed BioTech Digital Health 88

Digital Health Global

MARCH 2, 2023

This synergistic partnership is a combination of resources, talent and expertise across two leading science-based organizations with a mission of optimizing and accelerating therapies for patients in need, through greater adoption of digital biomarkers in clinical studies,” said Vik Shah, President and COO of Koneksa.

Life Science 88

Life Science Drug Development BioTech Leadership 88